These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27191185)

  • 1. Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.
    Gerona R; Wen A; Chin AT; Koss CA; Bacchetti P; Metcalfe J; Gandhi M
    PLoS One; 2016; 11(5):e0155887. PubMed ID: 27191185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care setting.
    Metcalfe J; Bacchetti P; Esmail A; Reckers A; Aguilar D; Wen A; Huo S; Muyindike WR; Hahn JA; Dheda K; Gandhi M; Gerona R
    BMC Infect Dis; 2021 Jan; 21(1):99. PubMed ID: 33482745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.
    Shayo GA; Moshiro C; Aboud S; Bakari M; Mugusi FM
    BMC Infect Dis; 2015 Aug; 15():368. PubMed ID: 26306511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid hair concentrations in children with tuberculosis: a proof of concept study.
    Mave V; Chandanwale A; Kinikar A; Khadse S; Kagal A; Gupte N; Suryavanshi N; Nimkar S; Koli H; Khwaja S; Bharadwaj R; Joshi S; Horng H; Benet LZ; Ramachandran G; Dooley KE; Gupta A; Gandhi M
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):844-7. PubMed ID: 27155191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
    Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
    AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study.
    Ngugi SK; Muiruri P; Odero T; Gachuno O
    BMC Infect Dis; 2020 Apr; 20(1):294. PubMed ID: 32664847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples.
    Reckers A; Wen A; Aguilar D; Bacchetti P; Gandhi M; Metcalfe J; Gerona R
    J Vis Exp; 2020 May; (159):. PubMed ID: 32510502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of latent tuberculosis infection in HIV infected persons.
    Akolo C; Adetifa I; Shepperd S; Volmink J
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD000171. PubMed ID: 20091503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a single tablet daily to treat latent tuberculosis infection in Brazil: bioequivalence of two different isoniazid formulations (300 mg and 100 mg) demonstrated by a sensitive and rapid high-performance liquid chromatography-tandem mass spectrometry method in a randomised, crossover study.
    Daher A; Pitta L; Santos T; Barreira D; Pinto D
    Mem Inst Oswaldo Cruz; 2015 Jun; 110(4):543-50. PubMed ID: 26038960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
    Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
    BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous analysis of 11 medications for drug resistant TB in small hair samples to quantify adherence and exposure using a validated LC-MS/MS panel.
    Gerona R; Wen A; Aguilar D; Shum J; Reckers A; Bacchetti P; Gandhi M; Metcalfe J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121729. PubMed ID: 31369929
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
    Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
    APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients.
    Khawcharoenporn T; Phetsuksiri B; Rudeeaneksin J; Srisungngam S; Apisarnthanarak A
    Jpn J Infect Dis; 2017 Sep; 70(5):502-506. PubMed ID: 28367883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
    Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
    J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care urine tests for smoking status and isoniazid treatment monitoring in adult patients.
    Nicolau I; Tian L; Menzies D; Ostiguy G; Pai M
    PLoS One; 2012; 7(9):e45913. PubMed ID: 23029310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine.
    McClintock AH; Eastment M; McKinney CM; Pitney CL; Narita M; Park DR; Dhanireddy S; Molnar A
    BMC Infect Dis; 2017 Feb; 17(1):146. PubMed ID: 28196479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
    Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
    BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.